HTGC Insider Trading

Insider Ownership Percentage: 1.90%
Insider Buying (Last 12 Months): $43,067.34
Insider Selling (Last 12 Months): $2,254,197.00

Hercules Capital Insider Trading History Chart

This chart shows the insider buying and selling history at Hercules Capital by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$1M$0$1MTotal Insider BuyingTotal Insider Selling

Hercules Capital Share Price & Price History

Current Price: $18.16
Price Change: Price Increase of +0.07 (0.39%)
As of 04/29/2025 04:59 PM ET

This chart shows the closing price history over time for HTGC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$18.16Closing price on 04/29/25:

SEC Filings (Institutional Ownership Changes) for Hercules Capital (NYSE:HTGC)

19.69% of Hercules Capital stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HTGC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$7.36Mbought$3MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100M-$50M$0$50M$100MTotal InflowsTotal Outflows
Hercules Capital logo
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, SaaS Finance, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels, and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, drug platform, development, and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. Within sustainable and renewables, it invests in Vehicle Technology, Energy Generation and Storage, Ag Technology, Advanced Materials, and Industry 4.0. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest, particularly in the areas of software, biotech, and information services. The firm prefers to invest between $5 million and $200 million in equity per transactions. It invests generally between $1 million and $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in December 2003 and is based in San Mateo, California with additional offices in North America and Europe.
Read More on Hercules Capital

Today's Range

Now: $18.16
Low: $17.79
High: $18.20

50 Day Range

MA: $18.57
Low: $16.19
High: $21.50

52 Week Range

Now: $18.16
Low: $15.65
High: $22.04

Volume

1,116,049 shs

Average Volume

1,060,768 shs

Market Capitalization

$3.19 billion

P/E Ratio

11.28

Dividend Yield

8.93%

Beta

1.13

Who are the company insiders with the largest holdings of Hercules Capital?

Hercules Capital's top insider shareholders include:
  1. Scott Bluestein (CEO)
  2. Christian Follmann (COO)
  3. Gayle A Crowell (Director)
  4. Nikos Theodosopoulos (Director)
  5. Robert P Badavas (Director)
Learn More about top insider investors at Hercules Capital.

Who are the major institutional investors of Hercules Capital?

Hercules Capital's top institutional shareholders include:
  1. Sound Income Strategies LLC — 1.66%
  2. Gilman Hill Asset Management LLC — 0.33%
  3. Sumitomo Mitsui Trust Group Inc. — 0.28%
  4. D.A. Davidson & CO. — 0.16%
  5. Golden State Wealth Management LLC — 0.12%
  6. Naviter Wealth LLC — 0.11%
Learn More about top institutional investors of Hercules Capital stock.

Which major investors are selling Hercules Capital stock?

In the last quarter, HTGC stock was sold by these institutional investors:
  1. Capital Advisory Group Advisory Services LLC
  2. Envestnet Asset Management Inc.
  3. Sowell Financial Services LLC
  4. Golden State Wealth Management LLC
  5. Cambridge Investment Research Advisors Inc.
  6. Gilman Hill Asset Management LLC
  7. Delphi Management Inc. MA
  8. D.A. Davidson & CO.
In the last year, company insiders that have sold Hercules Capital company stock include:
  1. Scott Bluestein (CEO)
  2. Christian Follmann (COO)
Learn More investors selling Hercules Capital stock.

Which major investors are buying Hercules Capital stock?

In the previous quarter, HTGC stock was acquired by institutional investors including:
  1. Golden State Wealth Management LLC
  2. Sound Income Strategies LLC
  3. Sumitomo Mitsui Trust Group Inc.
  4. Generali Investments CEE investicni spolecnost a.s.
  5. Bank of New York Mellon Corp
  6. Naviter Wealth LLC
  7. Summit Global Investments
  8. BigSur Wealth Management LLC
Within the last year, these company insiders have bought Hercules Capital stock:
  1. Scott Bluestein (CEO)
  2. Christian Follmann (COO)
  3. Gayle A Crowell (Director)
Learn More investors buying Hercules Capital stock.